- A/California/7/2009 (H1N1)pdm09-like virus
- A/Victoria/36/2011 (H3N2)-like virus
- B/Wisconsin/1/2010-like virus (from the B/Yamagata lineage of viruses)
The company has spent $600 million weighing a potential breakup.
Jefferies increased AstraZeneca's (AZN) stock rating to 'buy' this morning.
The drug company has several generic drugs that will compete with the likes of Pfizer's Viagra and Valeant's Acanya.